Bath & Body Works, Inc.
Financial highlights
| Metric | FY January 31, 2026 | FY February 1, 2025 | FY February 3, 2024 | FY January 28, 2023 | FY January 29, 2022 |
|---|---|---|---|---|---|
| Revenue | $7.3B | $7.3B | $7.4B | $7.6B | $7.9B |
| Gross profit | $3.2B | $3.2B | $3.2B | $3.3B | $3.9B |
| Operating income | $1.1B | $1.3B | $1.3B | $1.4B | $2.0B |
| Cost of revenue | $4.1B | $4.1B | $4.2B | $4.3B | $4.0B |
| Cash from operations | $1.1B | $886.0M | $954.0M | $1.1B | $1.5B |
| Capital expenditure | $237.0M | $226.0M | $298.0M | $328.0M | $270.0M |
| Free cash flow | $865.0M | $660.0M | $656.0M | $816.0M | $1.2B |
| Share repurchases | $401.0M | $401.0M | $148.0M | $1.3B | $2.0B |
| Impairments | — | — | — | $0 | $0 |
| Total assets | $5.1B | $4.9B | $5.5B | $5.5B | $6.0B |
| Total debt | — | $3.9B | $4.4B | $4.9B | $4.9B |
Shares outstanding 201.6M · Free float 88.6%
Annual filing data through FY ended January 31, 2026; float as of July 8, 2026.